Thursday, February 20, 2020
Tuesday, February 11, 2020
The trial has been using our Spinnaker Platform in a novel way, which is what this post is about!
Back in 2017 we were approached by Principle Investigator, Niklas Nielsen, looking for a way to streamline the collection of data for TTM2 and a similar study, TAME. The 2 studies had very similar data points to collect and there seemed to be an opportunity to save time by collecting data just once and sharing it across both studies. Very quickly it got more complicated than that. Patients could be randomised to TTM2, or TAME, or to participate in both studies. The big question was – could the Spinnaker Platform be adapted to this novel design?
We are very proud of our adaptability so we had a close look at what we could do ... follow the story on our blog »